Background:Antifungal resistance (AFR) is a global public health problem with devastating effects, especially among immunocompromised individuals. Addressing AFR requires a One Health approach including Antifungal Stewardship (AFS). This study aimed to comprehensively review global studies published on fungal infections and AFR and to recommend solutions to address this growing problem. Materials and Methods: This was a narrative review that was conducted using published papers on fungal infections, AFR, and AFS between January 1961 and March 2024. The literature was searched using PubMed, Google Scholar, Web of Science, and EMBASE. Results: This found that there has been an increase in fungal infections globally, especially among immunocompromised patients. Due to this increase in fungal infections, there has been a proportionate increase in the use of antifungal agents to prevent and treat fungal infections. This increased use of antifungal agents has worsened the problem of AFR contributing to increased morbidity and mortality. Globally, fungal infections have contributed to 150 million infections annually and 1.7 million deaths per year. By the year 2023, over 3.8 million people died from fungal infections. Addressing AFR remains a challenge because the treatment of antifungal-resistant infections is difficult. Finally, the treatment of fungal infections is a global challenge exacerbated by the limited number of antifungal agents to treat invasive fungal infections. Conclusion: The results of this study indicated that fungal infections and AFR are prevalent across humans, animals, agriculture, and the environment. Addressing this problem requires the provision of solutions such as improving the awareness of AFR, conducting further research on the discovery of new antifungal agents, and implementing AFS programs. If this global problem is not addressed, the morbidity and mortality associated with AFR will continue to rise in the future.
References
[1]
Kontoyiannis, D.P. (2017) Antifungal Resistance: An Emerging Reality and a Global Challenge. The Journal of Infectious Diseases, 216, S431-S435. https://doi.org/10.1093/infdis/jix179
[2]
Vitiello, A., Ferrara, F., Boccellino, M., Ponzo, A., Cimmino, C., Comberiati, E., Zovi, A., Clemente, S. and Sabbatucci, M. (2023) Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines, 11, Article 1063. https://doi.org/10.3390/biomedicines11041063
[3]
Mudenda, S., Matafwali, S.K., Mukosha, M., Daka, V., Chabalenge, B., Chizimu, J., Yamba, K., Mufwambi, W., Banda, P., Chisha, P., et al. (2023)Antifungal Resistance and Stewardship: A Knowledge, Attitudes and Practices Survey among Pharmacy Students at the University of Zambia; Findings and Implications. JAC-Antimicrobal Resistance, 5, dlad141. https://doi.org/10.1093/jacamr/dlad141
[4]
Arastehfar, A., Gabaldón, T., Garcia-Rubio, R., Jenks, J.D., Hoenigl, M., Salzer, H.J.F., Ilkit, M., Lass-Flörl, C. and Perlin, D.S. (2020) Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium. Antibiotics, 9, Article 877. https://doi.org/10.3390/antibiotics9120877
[5]
Berman, J. and Krysan, D.J. (2020) Drug Resistance and Tolerance in Fungi. Nature Reviews Microbiology, 18, 319-331. https://doi.org/10.1038/s41579-019-0322-2
[6]
Ben-Ami, R. and Kontoyiannis, D.P. (2021) Resistance to Antifungal Drugs. Infectious Disease Clinics of North America, 35, 279-311. https://doi.org/10.1016/j.idc.2021.03.003
[7]
Nicola, A.M., Albuquerque, P., Paes, H.C., Fernandes, L., Costa, F.F., Kioshima, E.S., Abadio, A.K.R., Bocca, A.L. and Felipe, M.S. (2019) Antifungal Drugs: New Insights in Research & Development. Pharmacology & Therapeutics, 195, 21-38. https://doi.org/10.1016/j.pharmthera.2018.10.008
[8]
Osherov, N. and Kontoyiannis, D.P. (2017) The Anti-Aspergillus Drug Pipeline: Is the Glass Half Full or Empty? Medical Mycology, 55, 118-124. https://doi.org/10.1093/mmy/myw060
[9]
Murray, C.J., Ikuta, K.S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022)Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. TheLancet, 399, 629-655. https://doi.org/10.1016/S0140-6736(21)02724-0
[10]
Prestinaci, F., Pezzotti, P. and Pantosti, A. (2015) Antimicrobial Resistance: A Global Multifaceted Phenomenon. Pathogens and Global Health, 109, 309-318. https://doi.org/10.1179/2047773215Y.0000000030
[11]
Tang, K.W.K., Millar, B.C. and Moore, J.E. (2023) Antimicrobial Resistance (AMR). British Journal of Biomedical Science, 80, Article 11387. https://doi.org/10.3389/bjbs.2023.11387
[12]
Arip, M., Selvaraja, M., Mogana, R., Tan, L.F., Leong, M.Y., Tan, P.L., Yap, V.L., Chinnapan, S., Tat, N.C., Abdullah, M., et al. (2022)Review on Plant-Based Management in Combating Antimicrobial Resistance—Mechanistic Perspective. Frontiers in Pharmacology, 13, Article 879495. https://doi.org/10.3389/fphar.2022.879495
[13]
Ikuta, K.S., Swetschinski, L.R., Robles Aguilar, G., Sharara, F., Mestrovic, T., Gray, A.P., Davis Weaver, N., Wool, E.E., Han, C., Gershberg Hayoon, A., et al. (2022)Global Mortality Associated with 33 Bacterial Pathogens in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. TheLancet, 400, 2221-2248. https://doi.org/10.1016/S0140-6736(22)02185-7
[14]
Srinivasan, A., Lopez-Ribot, J.L. and Ramasubramanian, A.K. (2014) Overcoming Antifungal Resistance. Drug Discovery Today: Technologies, 11, 65-71. https://doi.org/10.1016/j.ddtec.2014.02.005
[15]
Dadgostar, P. (2019) Antimicrobial Resistance: Implications and Costs. Infection and Drug Resistance, 12, 3903-3910. https://doi.org/10.2147/IDR.S234610
[16]
Jonas, O.B., Irwin, A., Berthe, F.C.J., Le Gall, F.G. and Marquez, P. (2017) Drug-Resistant Infections: A Threat to Our Economic Future. World Bank Report, 1-132. https://documents1.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf
[17]
O’Neill, J. (2014) Review on Antibiotic Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. https://wellcomecollection.org/works/rdpck35v
[18]
O’Neill, J. (2016) Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. The Review on Antimicrobial Resistance. https://amr-review.org/sites/default/files/160518_Final paper_with cover.pdf
[19]
World Health Organization (2022) WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, Vol. 1, 1-48. https://www.who.int/publications/i/item/9789240060241
[20]
Kainz, K., Bauer, M.A., Madeo, F. and Carmona-Gutierrez, D. (2020) Fungal Infections in Humans: The Silent Crisis. Microbial Cell, 7, 143-145. https://doi.org/10.15698/mic2020.06.718
[21]
Fang, W., Wu, J., Cheng, M., Zhu, X., Du, M., Chen, C., Liao, W., Zhi, K. and Pan, W. (2023) Diagnosis of Invasive Fungal Infections: Challenges and Recent Developments. Journal of Biomedical Science, 30, Article No. 42. https://doi.org/10.1186/s12929-023-00926-2
Calandra, T., Roberts, J.A., Antonelli, M., Bassetti, M. and Vincent, J.L. (2016) Diagnosis and Management of Invasive Candidiasis in the ICU: An Updated Approach to an Old Enemy. Critical Care, 20, Article No. 125. https://doi.org/10.1186/s13054-016-1313-6
[24]
Reddy, G.K.K., Padmavathi, A.R. and Nancharaiah, Y.V. (2022) Fungal Infections: Pathogenesis, Antifungals and Alternate Treatment Approaches. Current Research in Microbial Sciences, 3, Article 100137. https://doi.org/10.1016/j.crmicr.2022.100137
[25]
Verweij, P.E., Chowdhary, A., Melchers, W.J.G. and Meis, J.F. (2016) Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Clinical Infectious Diseases, 62, 362-368. https://doi.org/10.1093/cid/civ885
[26]
Koehler, P., Bassetti, M., Chakrabarti, A., Chen, S.C.A., Colombo, A.L., Hoenigl, M., Klimko, N., Lass-Flörl, C., Oladele, R.O., Vinh, D.C., et al. (2021)Defining and Managing COVID-19-Associated Pulmonary Aspergillosis: The 2020 ECMM/ISHAM Consensus Criteria for Research and Clinical Guidance. The Lancet Infectious Diseases, 21, e149-e162. https://doi.org/10.1016/S1473-3099(20)30847-1
[27]
van Arkel, A.L.E., Rijpstra, T.A., Belderbos, H.N.A., van Wijngaarden, P., Verweij, P.E. and Bentvelsen, R.G. (2020) COVID-19-Associated Pulmonary Aspergillosis. American Journal of Respiratory and Critical Care Medicine, 202, 132-135. https://doi.org/10.1164/rccm.202004-1038LE
[28]
Negm, E.M., Mohamed, M.S., Rabie, R.A., Fouad, W.S., Beniamen, A., Mosallem, A., Tawfik, A.E. and Salama, H.M. (2023) Fungal Infection Profile in Critically Ill COVID-19 Patients: A Prospective Study at a Large Teaching Hospital in a Middle-Income Country. BMC Infectious Diseases, 23, Article No. 246. https://doi.org/10.1186/s12879-023-08226-8
[29]
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G.H., Ibrahim, A.S. and Carvalho, A. (2022) COVID-19-Associated Fungal Infections. Nature Microbiology,7, 1127-1140. https://doi.org/10.1038/s41564-022-01172-2
[30]
Dubey, R., Sen, K.K., Mohanty, S.S., Panda, S., Goyal, M. and Menon, S.M. (2022) The Rising Burden of Invasive Fungal Infections in COVID-19, Can Structured CT Thorax Change the Game. Egyptian Journal of Radiology and Nuclear Medicine, 53, Article No. 18. https://doi.org/10.1186/s43055-022-00694-3
[31]
Arastehfar, A., Shaban, T., Zarrinfar, H., Roudbary, M., Ghazanfari, M., Hedayati, M.T., Sedaghat, A., Ilkit, M., Najafzadeh, M.J. and Perlin, D.S. (2021) Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs. Journal of Fungi, 7, Article 280. https://doi.org/10.3390/jof7040280
[32]
Villanueva-Lozano, H., Treviño-Rangel, R. de J., González, G.M., Ramírez-Elizondo, M.T., Lara-Medrano, R., Aleman-Bocanegra, M.C., Guajardo-Lara, C.E., Gaona-Chávez, N., Castilleja-Leal, F., Torre-Amione, G., et al. (2021)Outbreak of Candida auris Infection in a COVID-19 Hospital in Mexico. Clinical Microbiology and Infection, 27, 813-816. https://doi.org/10.1016/j.cmi.2020.12.030
[33]
Cataldo, M.A., Tetaj, N., Selleri, M., Marchioni, L., Capone, A., Caraffa, E., Di Caro, A. and Petrosillo, N. (2020) Incidence of Bacterial and Fungal Bloodstream Infections in COVID-19 Patients in Intensive Care: An Alarming “Collateral Effect”. Journal of Global Antimicrobial Resistance, 23, 290-291. https://doi.org/10.1016/j.jgar.2020.10.004
[34]
Ramadan, H.K.A., Mahmoud, M.A., Zakaria, M., Aburahma; Elkhawaga, A.A., El-Mokhtar, M.A., Sayed, I.M., Hosni, A., Hassany, S.M. and Medhat, M.A. (2020) Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt. Infection and Drug Resistance, 13, 3409-3422. https://doi.org/10.2147/IDR.S272605
[35]
Denning, D. (2024) Global Incidence and Mortality of Severe Fungal Disease. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(23)00692-8
[36]
Dall, C. (2024) Global Mortality from Fungal Diseases Has Nearly Doubled. https://www.cidrap.umn.edu/antimicrobial-stewardship/global-mortality-fungal-diseases-has-nearly-doubled
[37]
Ghannoum, M.A. and Rice, L.B. (1999) Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance. Clinical Microbiology Reviews, 12, 501-517. https://doi.org/10.1128/CMR.12.4.501
[38]
Nami, S., Aghebati-Maleki, A., Morovati, H. and Aghebati-Maleki, L. (2019) Current Antifungal Drugs and Immunotherapeutic Approaches as Promising Strategies to Treatment of Fungal Diseases. Biomedicine & Pharmacotherapy, 110, 857-868. https://doi.org/10.1016/j.biopha.2018.12.009
[39]
Hossain, C.M., Ryan, L.K., Gera, M., Choudhuri, S., Lyle, N., Ali, K.A. and Diamond, G. (2022) Antifungals and Drug Resistance. Encyclopedia, 2, 1722-1737. https://doi.org/10.3390/encyclopedia2040118
[40]
Fisher, M.C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E.M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O.A., et al. (2022)Tackling the Emerging Threat of Antifungal Resistance to Human Health. Nature Reviews Microbiology, 20, 557-571. https://doi.org/10.1038/s41579-022-00720-1
[41]
Robbins, N., Caplan, T. and Cowen, L.E. (2017) Molecular Evolution of Antifungal Drug Resistance. The Annual Review of Microbiology, 71, 753-775. https://doi.org/10.1146/annurev-micro-030117-020345
[42]
Pathadka, S., Yan, V.K.C., Neoh, C.F., Al-Badriyeh, D., Kong, D.C.M., Slavin, M.A., Cowling, B.J., Hung, I.F.N., Wong, I.C.K. and Chan, E.W. (2022) Global Consumption Trend of Antifungal Agents in Humans from 2008 to 2018: Data from 65 Middle-and High-Income Countries. Drugs, 82, 1193-1205. https://doi.org/10.1007/s40265-022-01751-x
[43]
Osset-Trénor, P., Pascual-Ahuir, A. and Proft, M. (2023) Fungal Drug Response and Antimicrobial Resistance. Journal of Fungi,9,Article565. https://doi.org/10.3390/jof9050565
[44]
Dhasarathan, P., AlSalhi, M.S., Devanesan, S., Subbiah, J., Ranjitsingh, A.J.A., Binsalah, M. and Alfuraydi, A.A. (2021) Drug Resistance in Candida albicans Isolates and Related Changes in the Structural Domain of Mdr1 Protein. Journal of Infection and Public Health, 14, 1848-1853. https://doi.org/10.1016/j.jiph.2021.11.002
[45]
Papadimitriou-Olivgeris, M., Andrianaki, A.M., Marangos, M., Sipsas, N., Apostolidi, E.A., Maltezos, E., Panagopoulos, P., Karapiperis, D., Arvaniti, K., Perdikouri, E.I., et al. (2020)Hospital-Wide Antifungal Prescription in Greek Hospitals: A Multicenter Repeated Point-Prevalence Study. European Journal of Clinical Microbiology & Infectious Diseases, 39, 243-248. https://doi.org/10.1007/s10096-019-03713-w
[46]
Russo, T.P. and Santaniello, A. (2023) Tackling Antibiotic and Antifungal Resistance in Domestic Animals, Synanthropic Species, and Wildlife: A Global Health Imperative. Antibiotics, 12, Article 1632. https://doi.org/10.3390/antibiotics12111632
[47]
Brauer, V.S., Rezende, C.P., Pessoni, A.M., De Paula, R.G., Rangappa, K.S., Nayaka, S.C., Gupta, V.K. and Almeida, F. (2019) Antifungal Agents in Agriculture: Friends and Foes of Public Health. Biomolecules, 9, Article 521. https://doi.org/10.3390/biom9100521
[48]
Miller, S.A., Ferreira, J.P. and Lejeune, J.T. (2022) Antimicrobial Use and Resistance in Plant Agriculture: A One Health Perspective. Agriculture, 12, Article 289. https://doi.org/10.3390/agriculture12020289
[49]
Monapathi, M.E., Oguegbulu, J.C., Adogo, L., Klink, M., Okoli, B., Mtunzi, F. and Modise, J.S. (2021) Pharmaceutical Pollution: Azole Antifungal Drugs and Resistance of Opportunistic Pathogenic Yeasts in Wastewater and Environmental Water. Applied and Environmental Soil Science, 2021, Article ID: 9985398. https://doi.org/10.1155/2021/9985398
[50]
Fisher, M.C., Hawkins, N.J., Sanglard, D. and Gurr, S.J. (2018) Worldwide Emergence of Resistance to Antifungal Drugs Challenges Human Health and Food Security. Science, 360, 739-742. https://doi.org/10.1126/science.aap7999
[51]
Osorio-Lombana, J.P., Cuervo-Maldonado, S.I., López-Mora, M.J. and Gómez-Rincón, J.C. (2019) Prescripción Inapropiada de Antifúngicos y La Necesidad de Programas Para Su Uso Racional. Revista Chilena de Infectología, 36, 403-413. https://doi.org/10.4067/S0716-10182019000400403
[52]
Mudenda, S., Daka, V., Matafwali, S.K., Kanaan, M.H.G., Abdullah, S.S., Mohamed, S., Mufwambi, W., Kasanga, M., Mulenga, B., Chabalenge, B., et al. (2023)Prevalence of Self-Medication and Associated Factors among Healthcare Students during the COVID-19 Pandemic: A Cross-Sectional Study at the University of Zambia. Open Journal of Social Sciences, 11, 340-363. https://doi.org/10.4236/jss.2023.1110021
[53]
Mudenda, S., Mukela, M., Matafwali, S., Banda, M., Mutati, R.K., Muungo, L.T., Daka, V., Saad, S.A.M., Bumbangi, F.N. and Chabalenge, B. (2022) Knowledge, Attitudes, and Practices towards Antibiotic Use and Antimicrobial Resistance among Pharmacy Students at the University of Zambia: Implications for Antimicrobial Stewardship Programmes. Scholars Academic Journal of Pharmacy, 11, 117-124. https://doi.org/10.36347/sajp.2022.v11i08.002
[54]
Ngoma, M.T., Sitali, D., Mudenda, S., Mukuma, M., Bumbangi, F.N., Bunuma, E., Skjerve, E. and Muma, J.B. (2024) Community Antibiotic Consumption and Associated Factors in Lusaka District of Zambia: Findings and Implications for Antimicrobial Resistance and Stewardship. JAC-Antimicrobal Resistance, 6, dlae034. https://doi.org/10.1093/jacamr/dlae034
[55]
Kalungia, A.C., Burger, J., Godman, B., de Oliveira Costa, J. and Simuwelu, C. (2016) Non-Prescription Sale and Dispensing of Antibiotics in Community Pharmacies in Zambia. Expert Review of Anti-Infective Therapy, 14, 1215-1223. https://doi.org/10.1080/14787210.2016.1227702
[56]
Morgan, D.J., Okeke, I.N., Laxminarayan, R., Perencevich, E.N. and Weisenberg, S. (2011) Non-Prescription Antimicrobial Use Worldwide: A Systematic Review. The Lancet Infectious Diseases, 11, 692-701. https://doi.org/10.1016/S1473-3099(11)70054-8
[57]
Langfeldt, A., Gold, J.A.W. and Chiller, T. (2022) Emerging Fungal Infections: From the Fields to the Clinic, Resistant Aspergillus fumigatus and Dermatophyte Species: A One Health Perspective on an Urgent Public Health Problem. Current Clinical Microbiology Reports, 9, 46-51. https://doi.org/10.1007/s40588-022-00181-3
[58]
Hassoun, N., Kassem, I.I., Hamze, M., El Tom, J., Papon, N. and Osman, M. (2023) Antifungal Use and Resistance in a Lower-Middle-Income Country: The Case of Lebanon. Antibiotics, 12, Article 1063. https://doi.org/10.3390/antibiotics12091413
[59]
Mudenda, S., Chilimboyi, R., Matafwali, S.K., Daka, V., Lindizyani Mfune, R., Arielle, L., Kemgne, M., Bumbangi, F.N., Hangoma, J., Chabalenge, B., et al. (2024)Hospital Prescribing Patterns of Antibiotics in Zambia Using the WHO Prescribing Indicators Post-COVID-19 Pandemic: Findings and Implications. JAC-Antimicrobal Resistance, 6, dlae023. https://doi.org/10.1093/jacamr/dlae023
[60]
Mudenda, S., Chomba, M., Chabalenge, B., Hikaambo, C.N., Banda, M., Daka, V., Zulu, A., Mukesela, A., Kasonde, M., Lukonde, P., et al. (2022)Antibiotic Prescribing Patterns in Adult Patients According to the WHO AWaRe Classification: A Multi-Facility Cross-Sectional Study in Primary Healthcare Hospitals in Lusaka, Zambia. Pharmacology & Pharmacy, 13, 379-392. https://doi.org/10.4236/pp.2022.1310029
[61]
Sono, T.M., Yeika, E., Cook, A., Kalungia, A., Opanga, S.A., Acolatse, J.E.E., Sefah, I.A., Jelić, A.G., Campbell, S., Lorenzetti, G., et al. (2023)Current Rates of Purchasing of Antibiotics without a Prescription across Sub-Saharan Africa; Rationale and Potential Programmes to Reduce Inappropriate Dispensing and Resistance. Expert Review of Anti-Infective Therapy, 21, 1025-1055. https://doi.org/10.1080/14787210.2023.2259106
[62]
Yamba, K., Mudenda, S., Mpabalwani, E., Mainda, G., Mukuma, M., Samutela, M.T., Lukwesa, C., Chizimu, J., Kaluba, C.K., Mutalange, M., et al. (2024)Antibiotic Prescribing Patterns and Carriage of Antibiotic-Resistant Escherichia Coli and Enterococcus Species in Healthy Individuals from Selected Communities in Lusaka and Ndola Districts, Zambia. JAC-Antimicrobal Resistance, 6, dlae027. https://doi.org/10.1093/jacamr/dlae027
[63]
Lamb, D., Kelly, D., Manning, N. and Kelly, S. (2006) Reduced Intracellular Accumulation of Azole Antifungal Results in Resistance in Candida albicans Isolate NCPF 3363. FEMS Microbiology Letters, 147, 189-193. https://doi.org/10.1111/j.1574-6968.1997.tb10240.x
[64]
Cowen, L.E., Sanglard, D., Howard, S.J., Rogers, P.D. and Perlin, D.S. (2015) Mechanisms of Antifungal Drug Resistance. Cold Spring Harbor Perspectives in Medicine, 5, a019752. https://doi.org/10.1101/cshperspect.a019752
[65]
Michaelides, P., Rosenthal, S.A., Sulzberger, M.B. and Witten, V.H. (1961) Trichophyton tonsurans Infection Resistant to Griseofulvin: A Case Demonstrating Clinical and in Vitro Resistance. Archives of Dermatology, 83, 988-990. https://doi.org/10.1001/archderm.1961.01580120100025
[66]
Wiederhold, N.P. (2017) Antifungal Resistance: Current Trends and Future Strategies to Combat. Infection and Drug Resistance, 10, 249-259. https://doi.org/10.2147/IDR.S124918
[67]
Arendrup, M.C. (2014) Update on Antifungal Resistance in Aspergillus and Candida. Clinical Microbiology and Infection, 20, 42-48. https://doi.org/10.1111/1469-0691.12513
[68]
Mayr, A. and Lass-Flörl, C. (2011) Epidemiology and Antifungal Resistance in Invasive Aspergillosis According to Primary Disease—Review of the Literature. European Journal of Medical Research, 16, 153-157. https://doi.org/10.1186/2047-783X-16-4-153
[69]
Sugui, J.A., Peterson, S.W., Figat, A., Hansen, B., Samson, R.A., Mellado, E., Cuenca-Estrella, M. and Kwon-Chung, K.J. (2014) Genetic Relatedness versus Biological Compatibility between Aspergillus fumigatus and Related Species. Journal of Clinical Microbiology, 52, 3707-3721. https://doi.org/10.1128/JCM.01704-14
[70]
Daneshnia, F., de Almeida Júnior, J.N., Ilkit, M., Lombardi, L., Perry, A.M., Gao, M., Nobile, C.J., Egger, M., Perlin, D.S., Zhai, B., et al. (2023)Worldwide Emergence of Fluconazole-Resistant Candida parapsilosis: Current Framework and Future Research Roadmap. The Lancet Microbe, 4, e470-e480. https://doi.org/10.1016/S2666-5247(23)00067-8
[71]
Park, S., Kelly, R., Kahn, J.N., Robles, J., Hsu, M.J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005)Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida Sp. Isolates. Antimicrobial Agents and Chemotherapy, 49, 3264-3273. https://doi.org/10.1128/AAC.49.8.3264-3273.2005
[72]
Walker, L.A., Gow, N.A.R. and Munro, C.A. (2010) Fungal Echinocandin Resistance. Fungal Genetics and Biology, 47, 117-126. https://doi.org/10.1016/j.fgb.2009.09.003
[73]
Denning, D.W. (2022) Antifungal Drug Resistance: An Update. European Journal of Hospital Pharmacy, 29, 109-112. https://doi.org/10.1136/ejhpharm-2020-002604
[74]
Bongomin, F., Gago, S., Oladele, R.O. and Denning, D.W. (2017) Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. Journal of Fungi, 3, Article 57. https://doi.org/10.3390/jof3040057
[75]
Peghin, M., Vena, A., Graziano, E., Giacobbe, D.R., Tascini, C. and Bassetti, M. (2022) Improving Management and Antimicrobial Stewardship for Bacterial and Fungal Infections in Hospitalized Patients with COVID-19. Therapeutic Advances in Infectious Disease, 9. https://doi.org/10.1177/20499361221095732
[76]
Mudenda, S., Chabalenge, B., Kasanga, M., Mufwambi, W., Mfune, R.L., Daka, V. and Matafwali, S.K. (2023) Antifungal Resistance and Stewardship: A Call to Action in Zambia. PAMJ, 45, Article 152. https://doi.org/10.11604/pamj.2023.45.152.41232
[77]
Micallef, C., Aliyu, S.H., Santos, R., Brown, N.M., Rosembert, D. and Enoch, D.A. (2014) Introduction of an Antifungal Stewardship Programme Targeting High-Cost Antifungals at a Tertiary Hospital in Cambridge, England. Journal of Antimicrobial Chemotherapy, 70, 1908-1911. https://doi.org/10.1093/jac/dkv040
[78]
Hamdy, R.F., Zaoutis, T.E. and Seo, S.K. (2017) Antifungal Stewardship Considerations for Adults and Pediatrics. Virulence, 8, 658-672. https://doi.org/10.1080/21505594.2016.1226721
[79]
Ray, A., Das, A. and Panda, S. (2023) Antifungal Stewardship: What We Need to Know. Indian Journal of Dermatology, Venereology and Leprology, 89, 5-11. https://doi.org/10.25259/IJDVL_91_2022
[80]
Kara, E., Metan, G., Bayraktar-Ekincioglu, A., Gulmez, D., Arikan-Akdagli, S., Demirkazik, F., Akova, M., Unal, S. and Uzun, O. (2021) Implementation of Pharmacist-Driven Antifungal Stewardship Program in a Tertiary Care Hospital. Antimicrobial Agents and Chemotherapy, 65, e00629-21. https://doi.org/10.1128/AAC.00629-21
[81]
Valerio, M., Muñoz, P., Rodríguez, C.G., Caliz, B., Padilla, B., Fernández-Cruz, A., Sánchez-Somolinos, M., Gijón, P., Peral, J., Gayoso, J., et al. (2015)Antifungal Stewardship in a Tertiary-Care Institution: A Bedside Intervention. Clinical Microbiology and Infection, 21, 492.e1-492.e9. https://doi.org/10.1016/j.cmi.2015.01.013
[82]
Firacative, C. (2020) Invasive Fungal Disease in Humans: Are We Aware of the Real Impact? Memórias do Instituto Oswaldo Cruz, 115, e200430. https://doi.org/10.1590/0074-02760200430
[83]
Mudenda, S., Chabalenge, B., Daka, V., Mfune, R.L., Salachi, K.I., Mohamed, S., Mufwambi, W., Kasanga, M., Matafwali, S.K., Mudenda, S., et al. (2023)Global Strategies to Combat Antimicrobial Resistance: A One Health Perspective. Pharmacology & Pharmacy, 14, 271-328. https://doi.org/10.4236/pp.2023.148020
[84]
Haque, M., McKimm, J., Sartelli, M., Dhingra, S., Labricciosa, F.M., Islam, S., Jahan, D., Nusrat, T., Chowdhury, T.S., Coccolini, F., et al. (2020)Strategies to Prevent Healthcare-Associated Infections: A Narrative Overview. Risk Management and Healthcare Policy, 13, 1765-1780. https://doi.org/10.2147/RMHP.S269315
[85]
Probst, V., Islamovic, F. and Mirza, A. (2021) Antimicrobial Stewardship Program in Pediatric Medicine. Pediatric Investigation, 5, 229-238. https://doi.org/10.1002/ped4.12292
[86]
Machowska, A. and Lundborg, C.S. (2019) Drivers of Irrational Use of Antibiotics in Europe. International Journal of Environmental Research and Public Health, 16, Article 27. https://doi.org/10.3390/ijerph16010027
[87]
Selvarajan, R., Obize, C., Sibanda, T., Abia, A.L.K. and Long, H. (2023) Evolution and Emergence of Antibiotic Resistance in Given Ecosystems: Possible Strategies for Addressing the Challenge of Antibiotic Resistance. Antibiotics, 12, Article 28. https://doi.org/10.3390/antibiotics12010028
Klepser, M.E., Ernst, E.J. and Pfaller, M.A. (1997) Update on Antifungal Resistance. Trends in Microbiology, 5, 372-375. https://doi.org/10.1016/S0966-842X(97)01108-6
[90]
Kanafani, Z.A. and Perfect, J.R. (2008) Resistance to Antifungal Agents: Mechanisms and Clinical Impact. Clinical Infectious Diseases, 46, 120-128. https://doi.org/10.1086/524071
[91]
Pfaller, M.A. (2012) Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment. The American Journal of Medicine, 125, S3-S13. https://doi.org/10.1016/j.amjmed.2011.11.001
[92]
Agrawal, S., Barnes, R., Brüggemann, R.J., Rautemaa-Richardson, R. and Warris, A. (2016) The Role of the Multidisciplinary Team in Antifungal Stewardship. Journal of Antimicrobial Chemotherapy, 71, ii37-ii42. https://doi.org/10.1093/jac/dkw395
[93]
Vandeputte, P., Ferrari, S. and Coste, A.T. (2012) Antifungal Resistance and New Strategies to Control Fungal Infections. International Journal of Microbiology, 2012, Article ID: 713687. https://doi.org/10.1155/2012/713687
[94]
Burki, T. (2023) WHO Publish Fungal Priority Pathogens List. The Lancet Microbe, 4, E74. https://doi.org/10.1016/S2666-5247(23)00003-4
[95]
Paneri, M., Sevta, P., Paneri, M. and Sevta, P. (2023) Overview of Antimicrobial Resistance: An Emerging Silent Pandemic. Global Journal of Medical Pharmaceutical and Biomedical Update, 18, 11. https://doi.org/10.25259/GJMPBU_153_2022
[96]
Pfavayi, L.T., Denning, D.W., Baker, S., Sibanda, E.N. and Mutapi, F. (2021) Determining the Burden of Fungal Infections in Zimbabwe. Scientific Reports, 11, Article No. 13240. https://doi.org/10.1038/s41598-021-92605-1
[97]
Prestel, C., Anderson, E., Forsberg, K., Lyman, M., de Perio, M.A., Kuhar, D., Edwards, K., Rivera, M., Shugart, A., Walters, M., et al. (2021)Candida auris Outbreak in a COVID-19 Specialty Care Unit—Florida, July-August 2020. Morbidity and Mortality Weekly Reports, 70, 56-57. https://doi.org/10.15585/mmwr.mm7002e3
[98]
Meijer, E.F.J., Dofferhoff, A.S.M., Hoiting, O. and Meis, J.F. (2021) COVID-19-Associated Pulmonary Aspergillosis: A Prospective Single-Center Dual Case Series. Mycoses, 64, 457-464. https://doi.org/10.1111/myc.13254
[99]
Rawson, T.M., Moore, L.S.P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G. and Holmes, A. (2020) Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. Clinical Infectious Diseases, 71, 2459-2468. https://doi.org/10.1093/cid/ciaa530
[100]
Nucci, M., Barreiros, G., Guimarães, L.F., Deriquehem, V.A.S., Castiñeiras, A.C. and Nouér, S.A. (2021) Increased Incidence of Candidemia in a Tertiary Care Hospital with the COVID-19 Pandemic. Mycoses, 64, 152-156. https://doi.org/10.1111/myc.13225
[101]
Falcone, M., Tiseo, G., Giordano, C., Leonildi, A., Menichini, M., Vecchione, A., Pistello, M., Guarracino, F., Ghiadoni, L., Forfori, F., et al. (2020)Predictors of Hospital-Acquired Bacterial and Fungal Superinfections in COVID-19: A Prospective Observational Study. Journal of Antimicrobial Chemotherapy, 76, 1078-1084. https://doi.org/10.1093/jac/dkaa530
[102]
Mastrangelo, A., Germinario, B.N., Ferrante, M., Frangi, C., Li Voti, R., Muccini, C. and Ripa, M. (2021) Candidemia in Coronavirus Disease 2019 (COVID-19) Patients: Incidence and Characteristics in a Prospective Cohort Compared with Historical Non-COVID-19 Controls. Clinical Infectious Diseases, 73, E2838-E2839. https://doi.org/10.1093/cid/ciaa1594
[103]
Lai, C.C. and Yu, W.L. (2021) COVID-19 Associated with Pulmonary Aspergillosis: A Literature Review. Journal of Microbiology, Immunology and Infection, 54, 46-53. https://doi.org/10.1016/j.jmii.2020.09.004
[104]
Magnasco, L., Mikulska, M., Giacobbe, D.R., Taramasso, L., Vena, A., Dentone, C., Dettori, S., Tutino, S., Labate, L., et al. (2021)Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the Covid-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship? Microorganisms, 9, Article 95. https://doi.org/10.3390/microorganisms9010095
[105]
Rodriguez, J.Y., Le Pape, P., Lopez, O., Esquea, K., Labiosa, A.L. and Alvarez-Moreno, C. (2021) Candida auris: A Latent Threat to Critically Ill Patients with Coronavirus Disease 2019. Clinical Infectious Diseases, 73, e2836-e2837. https://doi.org/10.1093/cid/ciaa1595
[106]
Arendrup, M.C. and Patterson, T.F. (2017) Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. The Journal of Infectious Diseases, 216, S445-S451. https://doi.org/10.1093/infdis/jix131
[107]
Pristov, K.E. and Ghannoum, M.A. (2019) Resistance of Candida to Azoles and Echinocandins Worldwide. Clinical Microbiology and Infection, 25, 792-798. https://doi.org/10.1016/j.cmi.2019.03.028
[108]
Perea, S. and Patterson, T.F. (2002) Antifungal Resistance in Pathogenic Fungi. Clinical Infectious Diseases, 35, 1073-1080. https://doi.org/10.1086/344058
[109]
Benedict, K., Whitham, H.K. and Jackson, B.R. (2022) Economic Burden of Fungal Diseases in the United States. Open Forum Infectious Diseases, 9, ofac097. https://doi.org/10.1093/ofid/ofac097
[110]
Warshaw, E.M. (2006) Evaluating Costs for Onychomycosis Treatments: A Practitioner’s Perspective. Journal of the American Podiatric Medical Association, 96, 38-52. https://doi.org/10.7547/0960038
[111]
Mei-Sheng Riley, M. (2021) Invasive Fungal Infections among Immunocompromised Patients in Critical Care Settings: Infection Prevention Risk Mitigation. Critical Care Nursing Clinics of North America, 33, 395-405. https://doi.org/10.1016/j.cnc.2021.07.002
[112]
Low, C.Y. and Rotstein, C. (2011) Emerging Fungal Infections in Immunocompromised Patients. F1000 Medicine Reports, 3, 14. https://doi.org/10.3410/M3-14
[113]
Xia, J., Wang, Z., Li, T., Lu, F., Sheng, D. and Huang, W. (2022) Immunosuppressed Patients with Clinically Diagnosed Invasive Fungal Infections: The Fungal Species Distribution, Antifungal Sensitivity and Associated Risk Factors in a Tertiary Hospital of Anhui Province. Infection and Drug Resistance, 15, 321-333. https://doi.org/10.2147/IDR.S351260
[114]
Robertson, E., Abera, C., Wood, K., Deressa, K., Mesfin, S. and Scantlebury, C. (2023) Striving towards Access to Essential Medicines for Human and Animal Health; a Situational Analysis of Access to and Use of Antifungal Medications for Histoplasmosis in Ethiopia. PLOS ONE, 18, e0278964. https://doi.org/10.1371/journal.pone.0278964
[115]
Roemer, T. and Krysan, D.J. (2014) Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches. Cold Spring Harbor Perspectives in Medicine, 4, a019703. https://doi.org/10.1101/cshperspect.a019703
[116]
Ahmad, A., Molepo, J. and Patel, M. (2016) Challenges in the Development of Antifungal Agents against Candida: Scope of Phytochemical Research. Current Pharmaceutical Design, 22, 4135-4150. https://doi.org/10.2174/1381612822666160607072748
[117]
Rodrigues, M.L. and Nosanchuk, J.D. (2023) Recognition of Fungal Priority Pathogens: What Next? PLOS Neglected Tropical Diseases, 17, e0011136. https://doi.org/10.1371/journal.pntd.0011136
[118]
Hudson, M.M.T. (2001) Antifungal Resistance and Over-the-Counter Availability in the UK: A Current Perspective. Journal of Antimicrobial Chemotherapy, 48, 345-350. https://doi.org/10.1093/jac/48.3.345
[119]
Kneale, M., Bartholomew, J.S., Davies, E. and Denning, D.W. (2016) Global Access to Antifungal Therapy and Its Variable Cost. Journal of Antimicrobial Chemotherapy, 71, 3599-3606. https://doi.org/10.1093/jac/dkw325
[120]
Khairy, W.A., Nasser, H.A., Sarhan, M.D., El Shamy, A.A. and Galal, Y.S. (2021) Prevalence and Predictors of Self-Medication with Antifungal Drugs and Herbal Products among University Students: A Cross-Sectional Study from Egypt. Risk Management and Healthcare Policy, 14, 2191-2200. https://doi.org/10.2147/RMHP.S308400
[121]
Revie, N.M., Iyer, K.R., Robbins, N. and Cowen, L.E. (2018) Antifungal Drug Resistance: Evolution, Mechanisms and Impact. Current Opinion in Microbiology, 45, 70-76. https://doi.org/10.1016/j.mib.2018.02.005
[122]
Zhao, Y., Ye, L., Zhao, F., Zhang, L., Lu, Z., Chu, T., Wang, S., Liu, Z., Sun, Y., Chen, M., et al. (2023)Cryptococcus neoformans, a Global Threat to Human Health. Infectious Diseases of Poverty, 12, Article No. 20. https://doi.org/10.1186/s40249-023-01073-4
[123]
Xu, J. (2022) Assessing Global Fungal Threats to Humans. mLife, 1, 223-240. https://doi.org/10.1002/mlf2.12036
[124]
Rhodes, J. (2019) Rapid Worldwide Emergence of Pathogenic Fungi. Cell Host & Microbe, 26, 12-14. https://doi.org/10.1016/j.chom.2019.06.009
[125]
Lima, R., Ribeiro, F.C., Colombo, A.L. and de Almeida, J.N. (2022) The Emerging Threat Antifungal-Resistant Candida tropicalis in Humans, Animals, and Environment. Frontiers in Fungal Biology, 3, Article 957021. https://doi.org/10.3389/ffunb.2022.957021
[126]
Drgona, L., Khachatryan, A., Stephens, J., Charbonneau, C., Kantecki, M., Haider, S. and Barnes, R. (2014) Clinical and Economic Burden of Invasive Fungal Diseases in Europe: Focus on Pre-Emptive and Empirical Treatment of Aspergillus and Candida Species. European Journal of Clinical Microbiology & Infectious Diseases, 33, 7-21. https://doi.org/10.1007/s10096-013-1944-3
[127]
Slobbe, L., Polinder, S., Doorduijn, J.K., Lugtenburg, P.J., El Barzouhi, A., Steyerberg, E.W. and Rijnders, B.J.A. (2008) Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia-Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study. Clinical Infectious Diseases, 47, 1507-1512. https://doi.org/10.1086/591531
[128]
Berger, S., Chazli, Y. El Babu, A.F. and Coste, A.T. (2017) Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture? Frontiers in Microbiology, 8, Article 1024. https://doi.org/10.3389/fmicb.2017.01024
[129]
Stevenson, E.M., Gaze, W.H., Gow, N.A.R., Hart, A., Schmidt, W., Usher, J., Warris, A., Wilkinson, H. and Murray, A.K. (2022) Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies. Frontiers in Fungal Biology, 3, Article 918717. https://doi.org/10.3389/ffunb.2022.918717
[130]
Burks, C., Darby, A., Londoño, L.G., Momany, M. and Brewer, M.T. (2021) Azole-Resistant Aspergillus fumigatus in the Environment: Identifying Key Reservoirs and Hotspots of Antifungal Resistance. PLOS Pathogens, 17, e1009711. https://doi.org/10.1371/journal.ppat.1009711
[131]
Picot, S., Beugnet, F., Leboucher, G. and Bienvenu, A.L. (2022) Drug Resistant Parasites and Fungi from a One-Health Perspective: A Global Concern That Needs Transdisciplinary Stewardship Programs. One Health, 14, Article 100368. https://doi.org/10.1016/j.onehlt.2021.100368
[132]
Verweij, P.E., Arendrup, M.C., Alastruey-Izquierdo, A., Gold, J.A.W., Lockhart, S.R., Chiller, T. and White, P.L. (2022) Dual Use of Antifungals in Medicine and Agriculture: How Do We Help Prevent Resistance Developing in Human Pathogens? Drug Resistance Updates, 65, Article 100885. https://doi.org/10.1016/j.drup.2022.100885
[133]
Verweij, P.E., Lucas, J.A., Arendrup, M.C., Bowyer, P., Brinkmann, A.J.F., Denning, D.W., Dyer, P.S., Fisher, M.C., Geenen, P.L., Gisi, U., et al. (2020)The One Health Problem of Azole Resistance in Aspergillus fumigatus: Current Insights and Future Research Agenda. Fungal Biology Reviews, 34, 202-214. https://doi.org/10.1016/j.fbr.2020.10.003
[134]
Sahu, S., Panda, A., Dash, S., Ramani, Y.R. and Behera, J. (2023) Changing Pattern of Antifungal Drug Resistance in a Tertiary Health-Care Facility—A Cross-Sectional Study. Current Medical Issues, 21, 208-213. https://doi.org/10.4103/cmi.cmi_63_23
[135]
Prajna, N.V., Lalitha, P., Krishnan, T., Rajaraman, R., Radnakrishnan, N., Srinivasan, M., Devi, L., Das, M., Liu, Z., Zegans, M.E., et al. (2022)Patterns of Antifungal Resistance in Adult Patients with Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials. JAMA Ophthalmology, 140, 179-184. https://doi.org/10.1001/jamaophthalmol.2021.5765
[136]
Sarma, S., Kumar, N., Sharma, S., Govil, D., Ali, T., Mehta, Y. and Rattan, A. (2013) Candidemia Caused by Amphotericin B and Fluconazole Resistant Candida auris. Indian Journal of Medical Microbiology, 31, 90-91. https://doi.org/10.4103/0255-0857.108746
[137]
Achilonu, C.C., Davies, A., Kanu, O.O., Noel, C.B. and Oladele, R. (2023) Recent Advances and Future Perspectives in Mitigating Invasive Antifungal-Resistant Pathogen Aspergillus fumigatus in Africa. Current Treatment Options in Infectious Diseases, 16, 14-33. https://doi.org/10.1007/s40506-023-00269-4
[138]
Allaw, F., Zahreddine, N.K., Ibrahim, A., Tannous, J., Taleb, H., Bizri, A.R., Dbaibo, G. and Kanj, S.S. (2021) First Candida auris Outbreak during a Covid-19 Pandemic in a Tertiary-Care Center in Lebanon. Pathogens, 10, Article 157. https://doi.org/10.3390/pathogens10020157
[139]
Jacobs, S.E., Jacobs, J.L., Dennis, E.K., Taimur, S., Rana, M., Patel, D., Gitman, M., Patel, G., Schaefer, S., Iyer, K., et al. (2022)Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents. Antimicrobial Agents and Chemotherapy, 66, e0005322. https://doi.org/10.1128/aac.00053-22
[140]
Purkait, B., Kumar, A., Nandi, N., Sardar, A.H., Das, S., Kumar, S., Pandey, K., Ravidas, V., Kumar, M., De, T., et al. (2012)Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani. Antimicrobial Agents and Chemotherapy, 56, 1031-1041. https://doi.org/10.1128/AAC.00030-11
[141]
Mano, C., Kongkaew, A., Tippawangkosol, P., Somboon, P., Roytrakul, S., Pescher, P., Späth, G.F., Uthaipibull, C., Tantiworawit, A., Siriyasatien, P., et al. (2023)Amphotericin B Resistance Correlates with Increased Fitness in Vitro and in Vivo in Leishmania (Mundinia) Martiniquensis. Frontiers in Microbiology, 14, Article 1156061. https://doi.org/10.3389/fmicb.2023.1156061
[142]
Silva, L.N., Oliveira, S.S.C., Magalhães, L.B., Andrade Neto, V. V., Torres-Santos, E.C., Carvalho, M.D.C., Pereira, M.D., Branquinha, M.H. and Santos, A.L.S. (2020) Unmasking the Amphotericin B Resistance Mechanisms in Candida haemulonii Species Complex. ACS Infectious Diseases, 6, 1273-1282. https://doi.org/10.1021/acsinfecdis.0c00117
[143]
Messer, S.A., Diekema, D.J., Boyken, L., Tendolkar, S., Hollis, R.J. and Pfaller, M.A. (2006) Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida Spp. Journal of Clinical Microbiology, 44, 324-326. https://doi.org/10.1128/JCM.44.2.324-326.2006
[144]
Alexander, B.D., Johnson, M.D., Pfeiffer, C.D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S.A., Perlin, D.S. and Pfaller, M.A. (2013) Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates with Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations. Clinical Infectious Diseases, 56, 1724-1732. https://doi.org/10.1093/cid/cit136
[145]
Healey, K.R. and Perlin, D.S. (2018) Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata. Journal of Fungi, 4, Article 105. https://doi.org/10.3390/jof4030105
[146]
Perlin, D.S. (2015) Mechanisms of Echinocandin Antifungal Drug Resistance. Annals of the New York Academy of Sciences, 1354, 1-11. https://doi.org/10.1111/nyas.12831
[147]
Farmakiotis, D., Tarrand, J.J. and Kontoyiannis, D.P. (2014) Drug-Resistant Candida glabrata Infection in Cancer Patients. Emerging Infectious Diseases, 20, 1833-1840. https://doi.org/10.3201/eid2011.140685
[148]
Thompson, G.R., Wiederhold, N.P., Vallor, A.C., Villareal, N.C., Lewis, J.S. and Patterson, T.F. (2008) Development of Caspofungin Resistance Following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection. Antimicrobial Agents and Chemotherapy, 52, 3783-3785. https://doi.org/10.1128/AAC.00473-08
[149]
Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K. and Yamaguchi, H. (2009) Candida auris Sp. Nov., a Novel Ascomycetous Yeast Isolated from the External Ear Canal of an Inpatient in a Japanese Hospital. Microbiology and Immunology, 53, 41-44. https://doi.org/10.1111/j.1348-0421.2008.00083.x
[150]
Chowdhary, A., Voss, A. and Meis, J.F. (2016) Multidrug-Resistant Candida auris: ‘New Kid on the Block’ in Hospital-Associated Infections? Journal of Hospital Infection, 94, 209-212. https://doi.org/10.1016/j.jhin.2016.08.004
[151]
Chowdhary, A., Tarai, B., Singh, A. and Sharma, A. (2020) Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020. Emerging Infectious Diseases, 26, 2694-2696. https://doi.org/10.3201/eid2611.203504
[152]
Pfaller, M.A., Messer, S.A., Moet, G.J., Jones, R.N. and Castanheira, M. (2011) Candida Bloodstream Infections: Comparison of Species Distribution and Resistance to Echinocandin and Azole Antifungal Agents in Intensive Care Unit (ICU) and Non-ICU Settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). International Journal of Antimicrobial Agents, 38, 65-69. https://doi.org/10.1016/j.ijantimicag.2011.02.016
[153]
Beyda, N.D., John, J., Kilic, A., Alam, M.J., Lasco, T.M. and Garey, K.W. (2014) FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients with Candidemia. Clinical Infectious Diseases, 59, 819-825. https://doi.org/10.1093/cid/ciu407
[154]
Pfaller, M.A., Castanheira, M., Messer, S.A. and Jones, R.N. (2015) In Vitro Antifungal Susceptibilities of Isolates of Candida Spp. and Aspergillus Spp. from China to Nine Systemically Active Antifungal Agents: Data from the SENTRY Antifungal Surveillance Program, 2010 through 2012. Mycoses, 58, 209-214. https://doi.org/10.1111/myc.12299
[155]
Xu, Z., Zhang, L., Han, R., Ding, C., Shou, H., Duan, X. and Zhang, S. (2023) A Candidemia Case Caused by a Novel Drug-Resistant Candida auris with the Y132f Mutation in Ergii in Mainland China. Infection and Drug Resistance, 16, 3065-3072. https://doi.org/10.2147/IDR.S409708
[156]
Khan, Z.U., Al-Sweih, N.A., Ahmad, S., Al-Kazemi, N., Khan, S., Joseph, L. and Chandy, R. (2007) Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and Fluconazole. Journal of Clinical Microbiology, 45, 2025-2027. https://doi.org/10.1128/JCM.00222-07
[157]
Kim, M.N., Shin, J.H., Sung, H., Lee, K., Kim, E.C., Ryoo, N., Lee, J.S., Jung, S.L., Park, K.H., Kee, S.J., et al. (2009)Candida haemulonii and Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features. Clinical Infectious Diseases, 48, e57-61. https://doi.org/10.1086/597108
[158]
Galia, L., Pezzani, M.D., Compri, M., Callegari, A., Rajendran, N.B., Carrara, E. and Tacconelli, E. (2022) Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries. Journal of Fungi, 8, Article 249. https://doi.org/10.3390/jof8030249
[159]
Woods, M., McAlister, J.A. and Geddes-McAlister, J. (2023) A One Health Approach to Overcoming Fungal Disease and Antifungal Resistance. WIREs Mechanisms of Disease, 15, e1610. https://doi.org/10.1002/wsbm.1610
[160]
Urbancic, K.F., Thursky, K., Kong, D.C.M., Johnson, P.D.R. and Slavin, M.A. (2018) Antifungal Stewardship: Developments in the Field. Current Opinion in Infectious Diseases, 31, 490-498. https://doi.org/10.1097/QCO.0000000000000497
[161]
Nivoix, Y., Launoy, A., Lutun, P., Moulin, J.C., Phai Pang, K.A., Fornecker, L.M., Wolf, M., Levěque, D., Letscher-Bru, V., Beretz, L., et al. (2012)Adherence to Recommendations for the Use of Antifungal Agents in a Tertiary Care Hospital. Journal of Antimicrobial Chemotherapy, 67, 2506-2513. https://doi.org/10.1093/jac/dks256
[162]
Albahar, F., Alhamad, H., Abu Assab, M., Abu-Farha, R., Alawi, L. and Khaleel, S. (2024) The Impact of Antifungal Stewardship on Clinical and Performance Measures: A Global Systematic Review. Tropical Medicine and Infectious Disease, 9, Article 8. https://doi.org/10.3390/tropicalmed9010008
[163]
Samura, M., Hirose, N., Kurata, T., Ishii, J., Nagumo, F., Takada, K., Koshioka, S., Uchida, M., Yamamoto, S., Inoue, J., et al. (2020)Support for Fungal Infection Treatment Mediated by Pharmacist-Led Antifungal Stewardship Activities. Journal of Infection and Chemotherapy, 26, 272-279. https://doi.org/10.1016/j.jiac.2019.09.016
[164]
Cook, P.P. and Gooch, M. (2015) Long-Term Effects of an Antimicrobial Stewardship Programme at a Tertiary-Care Teaching Hospital. International Journal of Antimicrobial Agents, 45, 262-267. https://doi.org/10.1016/j.ijantimicag.2014.11.006
[165]
Alegria, W. and Patel, P.K. (2021) The Current State of Antifungal Stewardship in Immunocompromised Populations. Journal of Fungi, 7, Article 352. https://doi.org/10.3390/jof7050352
[166]
Valerio, M., Muñoz, P., Rodríguez-González, C., Sanjurjo, M., Guinea, J. and Bouza, E. (2015) Training Should Be the First Step toward an Antifungal Stewardship Program. Enfermedades Infecciosas y Microbiología Clínica, 33, 221-227. https://doi.org/10.1016/j.eimc.2014.04.016
[167]
Mondain, V., Lieutier, F., Hasseine, L., Gari-Toussaint, M., Poiree, M., Lions, C. and Pulcini, C. (2013) A 6-Year Antifungal Stewardship Programme in a Teaching Hospital. Infection, 41, 621-628. https://doi.org/10.1007/s15010-013-0431-1
[168]
Talento, A.F., Qualie, M., Cottom, L., Backx, M. and White, P.L. (2021) Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and Ireland. Journal of Fungi, 7, Article 801. https://doi.org/10.3390/jof7100801
[169]
Mudenda, S., Daka, V. and Matafwali, S.K. (2023) World Health Organization AWaRe Framework for Antibiotic Stewardship: Where Are We Now and Where Do We Need to Go? An Expert Viewpoint. Antimicrobial Stewardship & Healthcare Epidemiology, 3, e84. https://doi.org/10.1017/ash.2023.164
[170]
World Health Organization (2023) AWaRe Classification of Antibiotics for Evaluation and Monitoring of Use. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.04
[171]
Graham, K., Sinyangwe, C., Nicholas, S., King, R., Mukupa, S., Källander, K., Counihan, H., Montague, M., Tibenderana, J. and Hamade, P. (2016) Rational Use of Antibiotics by Community Health Workers and Caregivers for Children with Suspected Pneumonia in Zambia: A Cross-Sectional Mixed Methods Study. BMC Public Health, 16, Article No. 897. https://doi.org/10.1186/s12889-016-3541-8
[172]
Hagen, T.L., Hertz, M.A., Uhrin, G.B., Dalager-Pedersen, M., Schønheyder, H.C. and Nielsen, H. (2017) Adherence to Local Antimicrobial Guidelines for Initial Treatment of Community-Acquired Infections. Danish Medical Journal, 64, A5381.
[173]
Mekonnen Eticha, E. and Gemechu, W.D. (2021) Adherence to Guidelines for Assessment and Empiric Antibiotics Recommendations for Community-Acquired Pneumonia at Ambo University Referral Hospital: Prospective Observational Study. Patient Preference and Adherence, 15, 467-473. https://doi.org/10.2147/PPA.S295118
[174]
Tell, D., Engström, S. and Mölstad, S. (2015) Adherence to Guidelines on Antibiotic Treatment for Respiratory Tract Infections in Various Categories of Physicians: A Retrospective Cross-Sectional Study of Data from Electronic Patient Records. BMJ Open, 5, e008096. https://doi.org/10.1136/bmjopen-2015-008096
[175]
Boltena, M.T., Woldie, M., Siraneh, Y., Steck, V., El-Khatib, Z. and Morankar, S. (2023) Adherence to Evidence-Based Implementation of Antimicrobial Treatment Guidelines among Prescribers in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Journal of Pharmaceutical Policy and Practice, 16, Article 137. https://doi.org/10.1186/s40545-023-00634-0
[176]
Wiedenmayer, K., Ombaka, E., Kabudi, B., Canavan, R., Rajkumar, S., Chilunda, F., Sungi, S. and Stoermer, M. (2021) Adherence to Standard Treatment Guidelines among Prescribers in Primary Healthcare Facilities in the Dodoma Region of Tanzania. BMC Health Services Research, 21, Article No. 272. https://doi.org/10.1186/s12913-021-06257-y
[177]
Metz, J., Oehler, P., Burggraf, M., Burdach, S., Behrends, U. and Rieber, N. (2019) Improvement of Guideline Adherence after the Implementation of an Antibiotic Stewardship Program in a Secondary Care Pediatric Hospital. Frontiers in Pediatrics, 7, Article 478. https://doi.org/10.3389/fped.2019.00478
[178]
Barlam, T.F., Cosgrove, S.E., Abbo, L.M., Macdougall, C., Schuetz, A.N., Septimus, E.J., Srinivasan, A., Dellit, T.H., Falck-Ytter, Y.T., Fishman, N.O., et al. (2016)Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62, e51-e77. https://doi.org/10.1093/cid/ciw118
[179]
Rabaan, A.A., Sulaiman, T., Al-Ahmed, S.H., Buhaliqah, Z.A., Buhaliqah, A.A., AlYuosof, B., Alfaresi, M., Al Fares, M.A., Alwarthan, S., Alkathlan, M.S., et al. (2023)Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review. Antibiotics, 12, Article 608. https://doi.org/10.3390/antibiotics12030608
[180]
McCarty, T.P. and Pappas, P.G. (2021) Antifungal Pipeline. Frontiers in Cellular and Infection Microbiology, 11, Article 732223. https://doi.org/10.3389/fcimb.2021.732223
[181]
Castelli, M.V., Butassi, E., Monteiro, M.C., Svetaz, L.A., Vicente, F. and Zacchino, S.A. (2014) Novel Antifungal Agents: A Patent Review (2011-Present). Expert Opinion on Therapeutic Patents, 24, 323-338. https://doi.org/10.1517/13543776.2014.876993
[182]
Fuentefria, A.M., Pippi, B., Dalla Lana, D.F., Donato, K.K. and de Andrade, S.F. (2018) Antifungals Discovery: An Insight into New Strategies to Combat Antifungal Resistance. Letters in Applied Microbiology, 66, 2-13. https://doi.org/10.1111/lam.12820
[183]
Durdu, M. and Ilkit, M. (2023) Strategies to Improve the Diagnosis and Clinical Treatment of Dermatophyte Infections. Expert Review of Anti-Infective Therapy, 21, 29-40. https://doi.org/10.1080/14787210.2023.2144232
[184]
Smith, D.J., Gold, J.A.W., Benedict, K., Wu, K., Lyman, M., Jordan, A., Medina, N., Lockhart, S.R., Sexton, D.J., Chow, N.A., et al. (2023)Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives. Journal of Fungi, 9, Article 820. https://doi.org/10.3390/jof9080820
[185]
Sanguinetti, M., Posteraro, B., Beigelman-Aubry, C., Lamoth, F., Dunet, V., Slavin, M. and Richardson, M.D. (2019) Diagnosis and Treatment of Invasive Fungal Infections: Looking Ahead. Journal of Antimicrobial Chemotherapy, 74, II27-II37. https://doi.org/10.1093/jac/dkz041
[186]
Scorzoni, L., de Paula e Silva, A.C.A., Marcos, C.M., Assato, P.A., de Melo, W.C.M.A., de Oliveira, H.C., Costa-Orlandi, C.B., Mendes-Giannini, M.J.S. and Fusco-Almeida, A.M. (2017) Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis. Frontiers in Microbiology, 8, Article 36. https://doi.org/10.3389/fmicb.2017.00036
[187]
Skosana, P.P., Mudenda, S., Demana, P.H. and Witika, B.A. (2023) Exploring Nanotechnology as a Strategy to Circumvent Antimicrobial Resistance in Bone and Joint Infections. ACS Omega, 8, 15865-15882. https://doi.org/10.1021/acsomega.3c01225
[188]
Mali, R. and Patil, J. (2023) Nanoparticles: A Novel Antifungal Drug Delivery System. Antibiotics, 14, Article 61. https://doi.org/10.3390/IOCN2023-14513
[189]
Al-Jedai, A.H., Almogbel, Y., Eljaaly, K., Alqahtani, N.M., Almudaiheem, H.Y., Awad, N., Alissa, D.A., Assiri, A. and Alaama, T. (2022) Restriction on Antimicrobial Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in the Community Pharmacies in Saudi Arabia. PLOS ONE, 17, e0271188. https://doi.org/10.1371/journal.pone.0271188
[190]
Rawson, T.M., Antcliffe, D.B., Wilson, R.C., Abdolrasouli, A. and Moore, L.S.P. (2023) Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations. Infection and Drug Resistance, 16, 2709-2726. https://doi.org/10.2147/IDR.S390946
[191]
Storr, J., Twyman, A., Zingg, W., Damani, N., Kilpatrick, C., Reilly, J., Price, L., Egger, M., Grayson, M.L., Kelley, E., et al. (2017)Core Components for Effective Infection Prevention and Control Programmes: New WHO Evidence-Based Recommendations. Antimicrobial Resistance & Infection Control, 6, Article No. 6. https://doi.org/10.1186/s13756-016-0149-9
[192]
Moore, D.P., Chetty, T., Pillay, A., Karsas, M., Cloete, J., Balakrishna, Y., Reddy, T., Archary, M., van Kwawegen, A., Thomas, R., et al. (2024)Antibiotic and Antifungal Use in Paediatric Departments at Three Academic Hospitals in South Africa. IJID Regions, 10, 151-158. https://doi.org/10.1016/j.ijregi.2023.12.004
[193]
Nagel, J.L., Kaye, K.S., LaPlante, K.L. and Pogue, J.M. (2016) Antimicrobial Stewardship for the Infection Control Practitioner. Infectious Disease Clinics of North America, 30, 771-784. https://doi.org/10.1016/j.idc.2016.04.012
[194]
Zhou, S., Nagel, J.L., Kaye, K.S., LaPlante, K.L., Albin, O.R. and Pogue, J.M. (2021) Antimicrobial Stewardship and the Infection Control Practitioner: A Natural Alliance. Infectious Disease Clinics of North America, 35, 771-787. https://doi.org/10.1016/j.idc.2021.04.011
[195]
Senbato, F.R., Wolde, D., Belina, M., Kotiso, K.S., Medhin, G., Amogne, W. and Eguale, T. (2024) Compliance with Infection Prevention and Control Standard Precautions and Factors Associated with Noncompliance among Healthcare Workers Working in Public Hospitals in Addis Ababa, Ethiopia. Antimicrobial Resistance & Infection Control, 13, Article No. 32. https://doi.org/10.1186/s13756-024-01381-w
[196]
Abalkhail, A. and Alslamah, T. (2022) Institutional Factors Associated with Infection Prevention and Control Practices Globally during the Infectious Pandemics in Resource-Limited Settings. Vaccines, 10, Article 1811. https://doi.org/10.3390/vaccines10111811
[197]
Das, A., Garg, R., Kumar, E.S., Singh, D., Ojha, B., Kharchandy, H.L., Pathak, B.K., Srikrishnan, P., Singh, R., Joshua, I., et al. (2022)Implementation of Infection Prevention and Control Practices in an Upcoming COVID-19 Hospital in India: An Opportunity Not Missed. PLOS ONE, 17, e0268071. https://doi.org/10.1371/journal.pone.0268071
[198]
Mustafa, Z.U., Majeed, H.K., Latif, S., Salman, M., Hayat, K., Mallhi, T.H., Khan, Y.H., Khan, A.H., Abubakar, U., Sultana, K., et al. (2023)Adherence to Infection Prevention and Control Measures among Health-Care Workers Serving in COVID-19 Treatment Centers in Punjab, Pakistan. Disaster Medicine and Public Health Preparedness, 17, e298. https://doi.org/10.1017/dmp.2022.252
[199]
Ling, M.L., Ching, P., Cheng, J., Lang, L., Liberali, S., Poon, P., Shin, Y. and Sim, C. (2023) APSIC Dental Infection Prevention and Control (IPC) Guidelines. Antimicrobial Resistance & Infection Control, 12, Article No. 53. https://doi.org/10.1186/s13756-023-01252-w
[200]
Gahamanyi, N., Umuhoza, T., Saeed, S.I., Mayigane, L.N. and Hakizimana, J.N. (2023) A Review of the Important Weapons against Antimicrobial Resistance in Sub-Saharan Africa. Applied Biosciences, 2, 136-156. https://doi.org/10.3390/applbiosci2020011
[201]
Ben-Ami, R., Halaburda, K., Klyasova, G., Metan, G., Torosian, T. and Akova, M. (2013) A Multidisciplinary Team Approach to the Management of Patients with: Suspected or Diagnosed Invasive Fungal Disease. Journal of Antimicrobial Chemotherapy, 68, iii25-iii33. https://doi.org/10.1093/jac/dkt390
[202]
Janssen, N.A.F., Brüggemann, R.J.M., Reijers, M.H., Henriet, S.S.V., Ten Oever, J., de Mast, Q., Berk, Y., de Kort, E.A., Kullberg, B.J., Netea, M.G., et al. (2020)A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology. Journal of Fungi, 6, Article 274. https://doi.org/10.3390/jof6040274
[203]
Ashiru-Oredope, D., Langford, B.J., Bonaconsa, C., Nampoothiri, V., Charani, E. and Goff, D.A. (2023) Global Collaborations in Antimicrobial Stewardship: All Hands on Deck. Antimicrobial Stewardship & Healthcare Epidemiology, 3, e66. https://doi.org/10.1017/ash.2023.122
[204]
Ashiru-Oredope, D., Nabiryo, M., Zengeni, L., Kamere, N., Makotose, A., Olaoye, O., Townsend, W., Waddingham, B., Matuluko, A., Nambatya, W., et al. (2023)Tackling Antimicrobial Resistance: Developing and Implementing Antimicrobial Stewardship Interventions in Four African Commonwealth Countries through a Health Partnership Model. Journal of Public Health in Africa, 14, 2335.
[205]
Lakoh, S., Bawoh, M., Lewis, H., Jalloh, I., Thomas, C., Barlatt, S., Jalloh, A., Deen, G.F., Russell, J.B.W., Kabba, M.S., et al. (2023)Establishing an Antimicrobial Stewardship Program in Sierra Leone: A Report of the Experience of a Low-Income Country in West Africa. Antibiotics, 12, Article 424. https://doi.org/10.3390/antibiotics12030424
[206]
Veepanattu, P., Singh, S., Mendelson, M., Nampoothiri, V., Edathadatil, F., Surendran, S., Bonaconsa, C., Mbamalu, O., Ahuja, S., Birgand, G., et al. (2020)Building Resilient and Responsive Research Collaborations to Tackle Antimicrobial Resistance—Lessons Learnt from India, South Africa, and UK. International Journal of Infectious Diseases, 100, 278-282. https://doi.org/10.1016/j.ijid.2020.08.057
[207]
Moyo, P., Moyo, E., Mangoya, D., Mhango, M., Mashe, T., Imran, M. and Dzinamarira, T. (2023) Prevention of Antimicrobial Resistance in Sub-Saharan Africa: What Has Worked? What Still Needs to Be Done? Journal of Infection and Public Health, 16, 632-639. https://doi.org/10.1016/j.jiph.2023.02.020
[208]
Musa, K., Okoliegbe, I., Abdalaziz, T., Aboushady, A.T., Stelling, J. and Gould, I.M. (2023) Laboratory Surveillance, Quality Management, and Its Role in Addressing Antimicrobial Resistance in Africa: A Narrative Review. Antibiotics, 12, Article 1313. https://doi.org/10.3390/antibiotics12081313
[209]
Iwu, C.D. and Patrick, S.M. (2021) An Insight into the Implementation of the Global Action Plan on Antimicrobial Resistance in the WHO African Region: A Roadmap for Action. International Journal of Antimicrobial Agents, 58, Article 106411. https://doi.org/10.1016/j.ijantimicag.2021.106411
[210]
Mader, R., Muñoz Madero, C., Aasmäe, B., Bourély, C., Broens, E.M., Busani, L., Callens, B., Collineau, L., Crespo-Robledo, P., Damborg, P., et al. (2022)Review and Analysis of National Monitoring Systems for Antimicrobial Resistance in Animal Bacterial Pathogens in Europe: A Basis for the Development of the European Antimicrobial Resistance Surveillance Network in Veterinary Medicine (EARS-Vet). Frontiers in Microbiology, 13, Article 807. https://doi.org/10.3389/fmicb.2022.838490
[211]
Arieti, F., Göpel, S., Sibani, M., Carrara, E., Pezzani, M.D., Murri, R., Mutters, N.T., Lòpez-Cerero, L., Voss, A., Cauda, R., et al. (2020)White Paper: Bridging the Gap between Surveillance Data and Antimicrobial Stewardship in the Outpatient Sector—Practical Guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net Networks. Journal of Antimicrobial Chemotherapy, 75, II42-II51. https://doi.org/10.1093/jac/dkaa428
[212]
He, S., Shrestha, P., Henry, A.D. and Legido-Quigley, H. (2023) Leveraging Collaborative Research Networks against Antimicrobial Resistance in Asia. Frontiers in Public Health, 11, Article 1191036. https://doi.org/10.3389/fpubh.2023.1191036
[213]
World Health Organization (2024) Regulation and Prequalification. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/regulatory-convergence-networks/harmonization?page=10
[214]
Kållberg, C., Mathiesen, L., Gopinathan, U. and Salvesen Blix, H. (2023) The Role of Drug Regulatory Authorities and Health Technology Assessment Agencies in Shaping Incentives for Antibiotic R&D: A Qualitative Study. Journal of Pharmaceutical Policy and Practice, 16, Article 53. https://doi.org/10.1186/s40545-023-00556-x
[215]
Kirchhelle, C., Atkinson, P., Broom, A., Chuengsatiansup, K., Ferreira, J.P., Fortané, N., Frost, I., Gradmann, C., Hinchliffe, S., Hoffman, S.J., et al. (2020)Setting the Standard: Multidisciplinary Hallmarks for Structural, Equitable and Tracked Antibiotic Policy. BMJ Global Health, 5, e003091. https://doi.org/10.1136/bmjgh-2020-003091
[216]
Muteeb, G., Rehman, M.T., Shahwan, M. and Aatif, M. (2023) Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals, 16, Article 1615. https://doi.org/10.3390/ph16111615
